Orphan Drug Act 1983
Sep 04, 2018
Orphan Drug Act and Its Criticism
The Orphan Drug Act of 1983 was created to encourage pharmaceutical companies to develop drugs for so-called rare or ultra-rare diseases. The National Institutes of Health (NIH) defines rare diseases as afflicting as fewer than 200,000 individuals. Generally speaking, it has worked. Many companies are willing to inv...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
